Literature DB >> 11244079

A mutation in the 5' untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus.

B Fournier1, Q C Truong-Bolduc, X Zhang, D C Hooper.   

Abstract

NorA, a multidrug efflux pump in Staphylococcus aureus, protects the cell from multiple drugs, including quinolones. The flqB mutation (T-->G) in the 5' untranslated region upstream of norA causes norA overexpression of 4.9-fold in cis, as measured in norA::blaZ fusions. The transcriptional initiation site of norA was unchanged in mutant and wild-type strains, but the half-life of norA mRNA was increased 4.8-fold in the flqB mutant compared to the wild-type strain. Computer-generated folding of the first 68 nucleotides of the norA transcript predicts an additional stem-loop and changes in a putative RNase III cleavage site in the flqB mutant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244079      PMCID: PMC95146          DOI: 10.1128/JB.183.7.2367-2371.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  29 in total

Review 1.  Messenger RNA stability and its role in control of gene expression in bacteria and phages.

Authors:  M Grunberg-Manago
Journal:  Annu Rev Genet       Date:  1999       Impact factor: 16.830

2.  Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system.

Authors:  B Fournier; R Aras; D C Hooper
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

3.  Different processing of an mRNA species in Bacillus subtilis and Escherichia coli.

Authors:  M Persson; E Glatz; B Rutberg
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

Review 4.  Quantitative RT-PCR: pitfalls and potential.

Authors:  W M Freeman; S J Walker; K E Vrana
Journal:  Biotechniques       Date:  1999-01       Impact factor: 1.993

5.  Translational fusion with a secretory enzyme as an indicator.

Authors:  P Z Wang; S J Projan; K R Leason; R P Novick
Journal:  J Bacteriol       Date:  1987-07       Impact factor: 3.490

6.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage.

Authors:  B N Kreiswirth; S Löfdahl; M J Betley; M O'Reilly; P M Schlievert; M S Bergdoll; R P Novick
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

7.  Confirmation of protoplast fusion-derived linkages in Staphylococcus aureus by transformation with protoplast DNA.

Authors:  M L Stahl; P A Pattee
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

8.  Classical and El Tor biotypes of Vibrio cholerae differ in timing of transcription of tcpPH during growth in inducing conditions.

Authors:  Y M Murley; J Behari; R Griffin; S B Calderwood
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

9.  The ompA 5' untranslated region impedes a major pathway for mRNA degradation in Escherichia coli.

Authors:  M J Hansen; L H Chen; M L Fejzo; J G Belasco
Journal:  Mol Microbiol       Date:  1994-06       Impact factor: 3.501

10.  Topography of intermediates in transcription initiation of E.coli.

Authors:  P Schickor; W Metzger; W Werel; H Lederer; H Heumann
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more
  29 in total

1.  The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter.

Authors:  Johnathan R Whetstine; Robin M Flatley; Larry H Matherly
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 2.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome.

Authors:  Norihisa Noguchi; Hidemasa Nakaminami; Setsuko Nishijima; Ichiro Kurokawa; Hiromu So; Masanori Sasatsu
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter.

Authors:  Glenn W Kaatz; Rama V Thyagarajan; Susan M Seo
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus.

Authors:  Carmen E DeMarco; Laurel A Cushing; Emmanuel Frempong-Manso; Susan M Seo; Tinevimbo A A Jaravaza; Glenn W Kaatz
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

6.  NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus.

Authors:  Que Chi Truong-Bolduc; Jacob Strahilevitz; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

7.  The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus.

Authors:  Que Chi Truong-Bolduc; David C Hooper
Journal:  J Bacteriol       Date:  2007-02-02       Impact factor: 3.490

8.  Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus.

Authors:  Que Chi Truong-Bolduc; Yanpeng Ding; David C Hooper
Journal:  J Bacteriol       Date:  2008-09-19       Impact factor: 3.490

9.  Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus.

Authors:  Que Chi Truong-Bolduc; Xiamei Zhang; David C Hooper
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

10.  The use of molecular beacons to directly measure bacterial mRNA abundances and transcript degradation.

Authors:  Lisa J Kuechenmeister; Kelsi L Anderson; John M Morrison; Paul M Dunman
Journal:  J Microbiol Methods       Date:  2008-10-25       Impact factor: 2.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.